18th week of 2014 patent applcation highlights part 56 |
Patent application number | Title | Published |
20140121255 | Methods of Treating Psoriasis Using Allantoin - Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0.5% to about 15.0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis herpetiform, contact dermatitis, arthritis, gout, lupus erythematosus, acne, alopecia, carcinomas, psoriasis, rosacea, miliaria, skin infections, post-operative care of incisions, post-operative skin care following any variety of plastic surgery operations, skin care following radiation treatment, care of dry, cracked or aged skin and skin lines as well as other conditions affecting the skin and having an inflammatory component, symptoms thereof, or a combination thereof. Symptoms treated may include pain, inflammation, redness, itching, scarring, skin thickening, milia, or a combination thereof. | 2014-05-01 |
20140121256 | METHOD OF TREATING MUSCULAR WEAKNESS COMPRISING ADMINISTERING A COMPOSITION COMPRISING AN EFFECTIVE AMOUNT OF HISTAMINE AND/OR SEROTONIN - The present invention relates to a treatment of muscle weakness resulting from a disease state or injury in a subject suffering therefrom by administering a composition including histamine in an amount effective to alleviate muscle weakness in the subject suffering therefrom. | 2014-05-01 |
20140121257 | ALPHA-1-ADRENERGIC RECEPTOR AGONIST THERAPY - Presented herein inter alia are novel methods of treating heart and brain diseases. | 2014-05-01 |
20140121258 | COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE - The present invention provides a compound, that is a 1-[(2-{[(alkyl or aryl)methyl]oxyl}halo or haloalkyl substituted-phenyl)alkyl]-5-hydrocarbyl or substituted hydrocarbyl-1H-pyrazole carboxylic acid or alkylenylcarboxylic acid or a hydrocarbyl or substituted hydrocarbyl sulfonamide of said carboxylic acid or said alkylenylcarboxylic acid, provided however said compound is not a 3-carboxylic acid, a sulfonamide thereof, or a 3-methylenylcarboxylic acid. The compound may be represented by the following formula (I). Wherein R1, R2, R3, R4, R5, R6, X, W, X and Y are as defined in the specification. The compounds may be administered to treat DP1, FP, EP1, TP and/or EP4 receptor mediated diseases or conditions. | 2014-05-01 |
20140121259 | NOVEL CRYSTALLINE ASENAPINE HYDROCHLORIDE SALT FORMS - Novel crystalline HCl salts of Asenapine, methods of their preparation and related pharmaceuticals and treatments are disclosed. | 2014-05-01 |
20140121260 | NOVEL CONJUGATES OF POLYUNSATURATED FATTY ACIDS WITH AMINES AND THERAPEUTIC USES THEREOF - The present application discloses conjugates comprising an aminic moiety covalently linked to a hydrophobic moiety, through an amidic bond, which are selective inhibitors of COX-2 enzyme and can be beneficially used in the treatment of various inflammatory disease or disorder and cancer. | 2014-05-01 |
20140121261 | C-MYC ANTISENSE OLIGONUCLEOTIDES AND METHODS FOR USING THE SAME TO TREAT CELL-PROLIFERATIVE DISORDERS - Provided herein are antisense oligonucleotides that can effectively prevent or decrease c-myc protein expression as well as decrease overall rates of cell proliferation in in vitro and mammalian in vivo models of cell proliferative disorders as well as methods for using the same. | 2014-05-01 |
20140121262 | Methods of Using microRNA-26a to Promote Angiogenesis - Methods for promoting angiogenesis, and for diagnosing the presence or risk of developing disorders associated with impaired angiogenesis or blood flow to a tissue in the body, using microRNA-26a (miR-26a). | 2014-05-01 |
20140121263 | LIPID FORMULATED DSRNA TARGETING THE PCSK9 GENE - This invention relates to composition and methods using lipid formulated siRNA targeted to a PCSK9 gene. | 2014-05-01 |
20140121264 | MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES - In some embodiments, the invention is directed to a method for diagnosing fibrosis and/or fibrosis related diseases and to a method for screening a pharmaceutically active compound for the treatment of fibrosis and/or fibrosis related diseases. The present invention further relates to compositions for use in the treatment, amelioration, and/or prevention of fibrosis. In certain embodiments, the compositions modulate the activity of a miRNA for the treatment, amelioration, and/or prevention of fibrosis. In certain embodiments, the compositions inhibit the activity of miR-21 for the treatment, amelioration, and/or prevention of fibrosis. | 2014-05-01 |
20140121265 | Restoration of Visual Responses by In Vivo Delivery of Rhodopsin Nucleic Acids - Nucleic acid vectors encoding light-gated cation-selective membrane channels, in particular channelrhodopsin-2 (Chop2), converted inner retinal neurons to photosensitive cells in photoreceptor-degenerated retina in an animal model. Such treatment restored visual perception and various aspects of vision. A method of restoring light sensitivity to a retina of a subject suffering from vision loss due to photoreceptor degeneration, as in retinitis pigmentosa or macular degeneration, is provided. The method comprises delivering to the subject by intravitreal or subretinal injection, the above nucleic acid vector which comprises an open reading frame encoding a rhodopsin, to which is operatively linked a promoter and transcriptional regulatory sequences, so that the nucleic acid is expressed in inner retinal neurons. These cells, normally light-insensitive, are converted to a light-sensitive state and transmit visual information to the brain, compensating for the loss, and leading to restoration of various visual capabilities. | 2014-05-01 |
20140121266 | Choline Esters - Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage. | 2014-05-01 |
20140121267 | METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA - Novel compounds of Formula A1 are provided: | 2014-05-01 |
20140121268 | Personal Care Compositions - A personal care composition exhibiting a tan delta of about 0.30 or more at about 10° C. includes a primary surfactant, secondary surfactant, and a polyol. Methods are also provided to improve the stability of a personal care composition. | 2014-05-01 |
20140121269 | FORMULATIONS AND METHODS TO PROVIDE NUTRITION TO HUMAN AND OTHER PATIENTS - Systems, techniques and methods for estimating the metabolic state or flux, e.g., the body energy state (“BES”) of a patient, are disclosed. The BES provides deep insight into the nutritional needs of the patient, thus allowing for a sort of exquisite glycemic control with regard to the patient. The invention discloses systems and methods for estimating fractional gluconeogenesis, which is the % of glucose production that comes from gluconeogenesis (“GNG”), as opposed to glycogenolysis (“GLY”), the other form of glucose production. Nutritional formulations, materials, cocktails and methods for feeding patients by parenteral and other means are disclosed. The amount, type and rate of such nutritional feeding are typically based upon the above estimating. The invention discloses formulations that contain labels, such as deuterium, for medical diagnostics, such as for estimating BES and fractional gluconeogenesis. The invention is suitable for any sort of patient, including those who are injured, such as with traumatic brain injury, ill, or have other conditions that stress the metabolic system. | 2014-05-01 |
20140121270 | FORMULATIONS AND METHODS TO PROVIDE NUTRITION TO HUMAN AND OTHER PATIENTS - Systems, techniques and methods for estimating the metabolic state or flux, e.g., the body energy state (“BES”) of a patient, are disclosed. The BES provides deep insight into the nutritional needs of the patient, thus allowing for a sort of exquisite glycemic control with regard to the patient. The invention discloses systems and methods for estimating fractional gluconeogenesis, which is the % of glucose production that comes from gluconeogenesis (“GNG”), as opposed to glycogenolysis (“GLY”), the other form of glucose production. Nutritional formulations, materials, cocktails and methods for feeding patients by parenteral and other means are disclosed. The amount, type and rate of such nutritional feeding are typically based upon the above estimating. The invention discloses formulations that contain labels, such as deuterium, for medical diagnostics, such as for estimating BES and fractional gluconeogenesis. The invention is suitable for any sort of patient, including those who are injured, such as with traumatic brain injury, ill, or have other conditions that stress the metabolic system. | 2014-05-01 |
20140121271 | NON-ENZYMATIC REMOVAL OF HYDROGEN PEROXIDE FROM PERACIDS - Peroxycarboxylic acid compositions having reduced hydrogen peroxide content are generated according to the invention, having enhanced antimicrobial efficacy. Simultaneously, a stable hydrogen peroxide and active oxygen coordinating compound complex is generated and has utility as a recycled bleaching component. In particular, methods of using an active oxygen coordinating compound to selectively and non-destructively remove hydrogen peroxide are provided. Preferred active oxygen coordinating compounds suitable for use with the peroxycarboxylic acid compositions include nitrogen-containing compounds, preferably urea, urea copolymers and/or derivatives, PVP, PVP copolymers and/or derivatives, and/or inorganic carbonates. | 2014-05-01 |
20140121272 | DEODORIZATION OF PEROXYCARBOXYLIC ACIDS USING CHAOTROPIC AGENTS - Treated peroxycarboxylic acid compositions and methods of using the same are provided to eliminate or reduce malodors associated therewith. Peroxycarboxylic acid compositions are treated with odor reducing agents, including various chaototropic agents. The invention further relates to methods employing the reduced odor peroxycarboxylic acid compositions. | 2014-05-01 |
20140121273 | METHOD FOR TREATMENT OF MAGNESIUM AND POTASSIUM DEFICIENCIES - A method for the treatment of depleted intracellular and serum magnesium levels by administration of a highly bioavailable magnesium salt is disclosed. A prescription dispensing system is also disclosed. The highly bioavailable magnesium salt can be administered alone or as adjunctive therapy in conjunction with various medications that cause or exacerbate depleted intracellular magnesium levels, such as renal magnesium wasting medications, including diuretics, immunosuppressants, chemotherapeutic agents, and antibiotics. The highly bioavailable magnesium salt can also be used as adjunctive therapy in conjunction with Class III anti-arrhythmic drugs to attenuate the QTc interval and reduce the risk of fatal arrhythmias, which are a common risk associated with Class III anti-arrhythmic drugs. The administration of a highly bioavailable magnesium salt also serves to restore intracellular potassium levels to normal ranges in patients who remain hypokalemic despite potassium therapy. | 2014-05-01 |
20140121274 | ACIDIC SOLID ORAL COMPOSITIONS WITHOUT EROSIVE POTENTIAL IN SALIVA AND METHOD FOR DETERMINING EROSIVE POTENTIAL IN SALIVA - Acidic oral compositions having calcium contents and effective pH-values in the area indicated by grey-tone in FIG. | 2014-05-01 |
20140121275 | Method of Feeding Livestock to Improve Carcass Characteristics - Feeding a diet supplemented with DDGS or another supplement containing UFA at a level above a threshold to animals such as swine, cattle, and poultry can have negative effects on carcass fat, certain growth parameters, and meat characteristics. However, if this diet is provided with a second supplement that contains CPFA at specified levels in the diet, the negative effects otherwise expected are wholly or at least partially countered. The invention recommends employing a supplemental source of CPFA between about 0.001% and about 0.5% of the diet by weight. Negative effects on carcass characteristics caused by ractopamine can also be countered by the addition of this amount of at least one source of CPFA in the diet. | 2014-05-01 |
20140121276 | METHOD FOR ALLEVIATING FEAR MEMORY - The present invention provides new methods of intervention for anxiety associated disorders, in particular, trauma-derived disorders such as PTSD, and therapeutic or prophylactic agents for anxiety associated disorders that can be used as foods, beverages, and dietary supplements, for example, and which contain as an active ingredient n-3 polyunsaturated fatty acids contained in krill oil or fish oil, for example. The present invention further provides methods for alleviating fear memory or methods for preventing its formation by adjusting the proportion of n-3 polyunsaturated fatty acids to n-6 polyunsaturated fatty acids as ingested. | 2014-05-01 |
20140121277 | USE OF METHIONINE SULFOXIMINE TO TREAT ACUTE LIVER FAILURE AND OTHER DISEASES CAUSED BY AN INFLAMMATORY CYTOKINE RESPONSE - Methods for treating or preventing an inflammatory response comprising administering an enantiomer or racemic mixture of methionine sulfoximine (MSO). The MSO may be L-methionine S-sulfoximine (LSMSO), L-methionine R-sulfoximine (LRMSO), or racemic mixture of LSMSO and LRMSO. Methods include those for treating liver failure associated with an inflammatory response. | 2014-05-01 |
20140121278 | ANTI-TUMOR AGENT OTX-008 TARGETS HUMAN GALECTIN-1 - Disclosed herein are compositions comprising a galectin-1-targeting compound in a therapeutically effective composition for treating cancer. In an aspect, a galectin-1-targeting compound is OTX-008. Also disclosed herein are methods of making and using such compositions. | 2014-05-01 |
20140121279 | Enkephalin Analogues - The present invention relates to dipeptide enkephalin analogues of Formula (I) and their tautomers, ionic forms and pharmaceutically acceptable salts, and their use in medicine, in particular as opioid agonists. | 2014-05-01 |
20140121280 | METHODS OF TREATMENT OF THE DENTAL PULP AND FILLING ROOT CANALS USING WATER-BASED MATERIAL - A dental composition comprising: a) about 1 to about 80% by weight of particulate material including: (i) calcium silicate, calcium aluminate, tetracalcium aluminoferrite, calcium phosphate, calcium sulfate, silica, alumina, calcium oxide, calcium hydroxide, or mixtures thereof; and b) about 1 to about 50% by weight liquid carrier including: (i) water-soluble polymer, (ii) surfactant, the surfactant is selected from the group consisting of alkyl sulfates, alkyl ether sulfates, and sarcosinates, and mixtures thereof; and (iii) water; wherein the particulate and liquid carrier being mixed together to form a hydrate gel material that can harden. | 2014-05-01 |
20140121281 | CATIONIC MICELLES WITH ANIONIC POLYMERIC COUNTERIONS METHODS THEREOF - The invention relates to polymer-micelle complex. The polymer-micelle complexes include a positively charged micelle selected from the group consisting of a monomeric quaternary ammonium compound, a monomeric biguanide compound, and mixtures thereof. The positively charged micelle is electrostatically bound to a water-soluble polymer bearing a negative charge. The polymer does not comprise block copolymer, latex particles, polymer nanoparticles, cross-linked polymers, silicone copolymer, fluorosurfactant, or amphoteric copolymer. The compositions do not form a coacervate, and do not form a film when applied to a surface. | 2014-05-01 |
20140121282 | PHENYL SUBSTITUTED CYCLOALKYLAMINES AS MONOAMINE REUPTAKE INHIBITORS - Phenyl-substituted cyclohexylamine derivatives and method for their synthesis and characterization are disclosed. Use of these compounds to treat/prevent neurological disorders as well as methods for their synthesis are set forth herein. Exemplary compounds of the invention inhibit reuptake of endogenous monoamines, such as dopamine, serotonin and norepinephrine (e.g., from the synaptic cleft) and modulate one or more monoamine transporter. Pharmaceutical formulations incorporating compounds of the invention are also provided. | 2014-05-01 |
20140121283 | METHODS OF USING DERIVATIVES OF (-)-VENLAFAXINE - Methods of preparing, and compositions comprising, derivatives of (−)-venlafaxine are disclosed. Also disclosed are methods of treating and preventing diseases and disorders including, but not limited to, affective disorders such as depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease, epilepsy, cerebral function disorders, obesity and weight gain, incontinence, dementia and related disorders. | 2014-05-01 |
20140121284 | Stable Pharmaceutical Composition - Provided is a stable pharmaceutical composition having as an active ingredient a therapeutically effective amount of R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof, an absorption modulator, and a diluent, wherein the absorption modulator is glycerin, and the diluent is anhydrous dibasic calcium phosphate (CaHPO | 2014-05-01 |
20140121285 | Low-Foam Preparations for Crop Protection - Alkyl ether sulfates having 1 to 9 carbon atoms in the alkyl chain and 1 to 20 alkyleneoxy units in the ether moiety are suitable for use as low-foam additives for enhancing the activity of water-soluble or partially water-soluble agrochemicals. They can be used to produce low-foam preparations for crop protection. | 2014-05-01 |
20140121286 | Cosmetic Compositions Containing Esters Based on 2-Propylheptanol - Esters of 2-propylheptanol with linear or branched, saturated or unsaturated C | 2014-05-01 |
20140121287 | MOLECULAR GRAM STAIN - The present invention relates to peptide nucleic acid (PNA) probes, PNA probe sets and methods for the analysis of Gram positive and Gram negative organisms optionally present in a sample. The invention further relates to diagnostic kits comprising such PNA probes. | 2014-05-01 |
20140121288 | ALDEHYDE ABATEMENT WITH POROUS AMINE FUNCTIONAL RESINS - The present invention addresses a need in the art by providing a composition comprising an aqueous dispersion of a binder and porous ion exchange resin particles that are functionalized with primary amine groups or secondary amine groups or both. The composition of the present invention provides an efficient way of removing aldehydes from or in the vicinity of a coating prepared from the composition. | 2014-05-01 |
20140121289 | ORGANIC-INORGANIC COMPOSITE MOLDED PRODUCT AND OPTICAL ELEMENT - An organic-inorganic composite molded product formed by molding a composite material of an organic resin and inorganic fine particles is provided, and in this molded product, the average primary particle diameter of the inorganic fine particles is 1 to 30 nm, the concentration of the inorganic fine particles is 25 to 50 percent by volume, and the porosity is 20 to 55 percent by volume. Accordingly, an organic-inorganic composite molded product having a small content of the inorganic fine particles and a significantly low average coefficient of linear expansion of 20*10 | 2014-05-01 |
20140121290 | FLEXIBLE POLYURETHANE FOAM AND METHOD OF PRODUCING SAME - A flexible polyurethane foam comprises the reaction product of an isocyanate component and an isocyanate-reactive component in the presence of a blowing agent. The isocyanate component comprises a polymeric diphenylmethane diisocyanate component and a monomeric diphenylmethane diisocyanate component. The monomeric diphenylmethane diisocyanate component comprises 2,4′-diphenylmethane diisocyanate and 4,4′-diphenylmethane diisocyanate. The flexible polyurethane foam is substantially free of supplemental flame retardant additives and exhibits flame retardance under flammability tests according to California Technical Bulletin 117 regulations. | 2014-05-01 |
20140121291 | Radiation Curable Polymers - A polymeric matrix is melt processed with reactive monomers or oligomers that are miscible in the polymeric matrix. Upon initial melt processing and mixing, the reactive monomers or oligomers contained within the resulting polymeric matrix are cured with actinic radiation to form a polymeric alloy. The alloy of the polymeric matrix and the cured polymer possesses a non-Cequilibrium morphology and a surface energy that is effectively secured for a desired application and use after subsequent compounding. | 2014-05-01 |
20140121292 | CURABLE COMPOSITION FOR IMPRINTS, PATTERNING METHOD AND PATTERN - Provided is a curable composition for imprints having good patternability and dry etching resistance. Disclosed is a curable composition for imprints comprising at least one kind of polymerizable monomer selected from the following compounds and a photopolymerization initiator; | 2014-05-01 |
20140121293 | Composition and Polymer - Disclosed is a composition comprising (A) at least one compound selected from the group consisting of an ether compound having two or more ether groups, a trivalent phosphorus compound, and a ketone compound, (B) a boron trihalide, and (C) an episulfide compound. | 2014-05-01 |
20140121294 | METHODS FOR FABRICATING POLYMER-BIOCERAMIC COMPOSITE IMPLANTABLE MEDICAL DEVICES - Methods relating to polymer-bioceramic composite implantable medical devices are disclosed. | 2014-05-01 |
20140121295 | SHAPE MEMORY POLYMER - A polymer is composed of a linear chain acrylate and a multi-functional acrylate cross-linker. The polymerized composition exhibits a transition at a temperature between about 34° C. and about 50° C. The polymerized composition exhibits shape memory effects. In one embodiment, the linear chain is tert-butyl acrylate and the crosslinker is polyethylene glycol dimethacrylate. The resultant shape memory polymers may be used in medical devices to provide devices with different shapes for pre and post implantation. | 2014-05-01 |
20140121296 | HYDROPHILIC AGENTS IN PAINTS - Coating compositions that provide hydrophilic and anti-freeze properties are disclosed. The coatings include at least one hydrophilic agent bound to one or more coating components, such as a rheology modifier, a surfactant, a coalescing agent, and a pigment. The hydrophilic agents are attached to the coating components covalently. | 2014-05-01 |
20140121297 | Solar Reflective Coating - Presented are solar reflective coating compositions comprising a mixture of polymeric binder system of acrylic and alkyd dispersion. Also presented are various fillers and pigments of high infra-red (IR) reflecting property of large crystalline size containing aluminum dioxide, titanium dioxide, aluminum trihydrate and silicon dioxide particles. | 2014-05-01 |
20140121298 | Method of Powder Coating and Powder-Coated Fuser Member - Methods for powder coating that include applying a powder coating composition to a substrate via an electrostatic gun. The powder coating composition includes a mixture of two or more materials having different densities, such as a mixture of aerogel particles and fluoropolymer-containing particles. The electrostatic gun can have a high-voltage generator that generates a negative polarity voltage between about 0 KV and about 100 KV during application of the powder coating composition, and the electrostatic gun can have a round spray nozzle. Methods of making fuser members using such powder coating methods, fuser members prepared by such methods, and methods of preparing low gloss images using such fuser members. | 2014-05-01 |
20140121299 | ADDUCTS AS TOUGHENERS IN THERMOSETTABLE EPOXY SYSTEMS - A liquid adduct consisting essentially of a reaction product of (a) an aliphatic epoxy resin, and (b) an isocyanate compound, wherein the viscosity of the adduct comprises less than about 60 Pa-s at about 25° C. is disclosed. The adduct can be used in an epoxy resin composition. | 2014-05-01 |
20140121300 | CARBON FIBROUS CONJUNCT AND COMPOSITE MATERIAL USING THEREOF - The disclosed is a carbon fibrous conjunct in a granule form which comprises carbon fibrous structures and a binder by which the carbon fibrous structures are bound together,
| 2014-05-01 |
20140121301 | ENGINEERED COMPOSITE MATERIAL AND PRODUCTS PRODUCED THEREFROM - A composite material includes a polymer matrix material and filler material that includes vitreous china. The composite material has a water absorption of less than about one percent. Such a composite material may be used in the production of articles such as sinks, bathtubs, shower receptors, and other articles that may benefit from low water absorption properties. | 2014-05-01 |
20140121302 | Cementitious Material for Cold Weather Applications - Disclosed is a cementitious material that possesses favorable adhesion and compressive strength properties and is suitable for cold weather applications. Disclosed also are methods for the manufacture and use of the material. | 2014-05-01 |
20140121303 | GYPSUM-CONTAINING CONSTRUCTION MATERIAL COMPOUNDS - The invention relates to gypsum-containing construction material compounds, containing gypsum, if necessary one or more polymers, if necessary one or more aggregates, and if necessary one or more additives, characterised in that the gypsum-containing construction material compounds contain one or more types of cement and one or more types of pozzolana. | 2014-05-01 |
20140121304 | METHOD OF PREPARING SOY FLOUR DISPERSIONS USING AN EXTRUDER - The present invention provides continuous methods of making ready to use aqueous soy binders comprising extruding in a twin screw extruder wet non-water soluble soy flour in grind phase mixing and, downstream, including further a polycarboxy emulsion copolymer in distributive phase mixing, wherein in the aqueous binders the amount of soy flour solids ranges from 51 to 95 wt. %, based on the total weight of binder solids. The present invention provides continuous and simple methods for providing aqueous binders wherein the soy flour has a sieve particle size ranging from 5 to 44 μm. Making soy flours of such a particle size enables soy flour binder compositions useful as binders for non-wovens, such as mineral fiber or glass mats. | 2014-05-01 |
20140121305 | COMPOSITION CONTAINING ASSOCIATIVE RHEOLOGY MODIFIER AND POLYMER ENCAPSULATED PIGMENT PARTICLES - The present invention relates to a composition comprising an associative thickener, a binder, polymer encapsulated opacifying pigment particles, and water. The composition of the present invention shows an improvement in opacity and S/mil over similar compositions that do not include polymer encapsulated opacifying pigment particles. | 2014-05-01 |
20140121306 | Fire-Resistant Cellulosic Material - A new approach for improving fire resistance of cellulosic materials is provided, especially when the cellulosic material is to be used in polymer composites. Cellulosic material is treated with an aqueous mixture of alkali metal or ammonium hydroxide and alkaline earth or aluminum metal salt simultaneously with or within a short period of time of preparing the mixture. The treated cellulosic material becomes self-extinguishing and may also have improved thermal stability, improved interfacial thermal resistance, improved resistance to damage by oxidants and other chemical agents, improved resistance to biological agents and/or improved resistance to damage by ultra-violet light. The fire-resistant cellulosic material may also be treated with a layered nanoparticulate material either simultaneously with, subsequent to or prior to treatment with the aqueous mixture of alkali metal or ammonium hydroxide and alkaline earth or aluminum metal salt to impart further fire resistance to the cellulosic material. Polymer composites produced from cellulosic material treated according to the present invention have significantly improved fire resistance with small negative impact on the mechanical performance of the composite, and may have the added benefit of improved thermal stability, improved interfacial thermal resistance, improved resistance to damage by oxidants and other chemical agents, improved resistance to biological agents and/or improved resistance to damage by ultra-violet light. | 2014-05-01 |
20140121307 | BLENDING LIGNIN WITH THERMOPLASTICS AND A COUPLING AGENT OR COMPATIBILIZER - A composition is provided in one example embodiment and includes a modified lignin, a thermoplastic, and a compatibilizer. The modified lignin may be between about 5% to about 50% by weight of the composition. Also, the modified lignin may be a Hydroxypropyl Lignin (HPL). In an example, the thermoplastic can include a High Density Polyethylene (HDPE). In another example, the thermoplastic can include a Low Density Polyethylene (LDPE). In yet another example, the thermoplastic can include a Linear Low Density Polyethylene (LLDPE). The compatibilizer may be a Maleic Anhydride grafted Polyethylene Blend (MAh-g-PE). | 2014-05-01 |
20140121308 | RUBBER COMPOSITION WITH ENCAPSULATED RESIN AND PNEUMATIC TIRE - The present invention is directed to a vulcanizable rubber composition comprising at least one diene based elastomer and an in-situ resin, the in-situ resin comprising a methylene acceptor and a methylene donor, wherein one of the methylene acceptor and methylene donor is microencapsulated. | 2014-05-01 |
20140121309 | ORGANIC COLOURING AGENTS AND COLOURED POLYMER COMPOSITIONS WITH A HIGH STABILITY TO WEATHERING - The present invention relates to organic colouring agents with a high colour stability to weathering for thermoplastics. The invention furthermore relates to a polymer composition containing at least one thermoplastic and at least one organic colouring agent, preferably a combination of at least two organic colouring agents, of a specific structure. The invention moreover relates to the use of the colouring agents according to the invention for colouring polymer compositions, in particular for transparent formulations such as are required for the production of panes for use in buildings, motor vehicles and track vehicles or aircraft. | 2014-05-01 |
20140121310 | FORMULATION WITH DEFOAMER - The present invention relates to a composition comprising an aqueous dispersion of a binder and from 0.01 to 2 weight percent, based on the weight of the binder, of a defoamer characterized by the following structure: | 2014-05-01 |
20140121311 | Paint Binder Composition - The present invention relates to composition and use of a binder for the production of paints and inks. Said binder comprises the following elements: waxes, emulsifying agents, curing agents, drying oils, resins, metal ions and water. Furthermore, the present invention discloses a process for the preparation of binder compositions and paints containing them. | 2014-05-01 |
20140121312 | Stearic Acid-Treated Calcium Carbonate Compositions Having Low or No Detectable Free Stearic Acid and Related Methods - A method for treating calcium carbonate includes combining calcium carbonate with an amount of stearic acid and an amount of water to form a mixture, the amount of water being at least about 0.1% by weight relative to the total weight. The method further includes blending the mixture to form a stearic acid-treated calcium carbonate composition. | 2014-05-01 |
20140121313 | Resin Compositions - Compositions comprising unsaturated resin and catalyst comprising transition metal, such as a complex of ligands and transition metals. The compositions may further comprise filler or rheology modifiers. | 2014-05-01 |
20140121314 | TREATED INORGANIC PIGMENTS HAVING REDUCED PHOTOACTIVITY AND IMPROVED ANTI-MICROBIAL PROPERTIES AND THEIR USE IN POLYMER COMPOSITIONS - The disclosure provides a polymer composition comprising a treated inorganic particle having improved photostability and improved anti-microbial properties, wherein the treated inorganic particle comprises: a inorganic core particle; a first treatment of a silicon compound, wherein the silicon compound is added in a single step; and a second treatment comprising a co-precipitated zinc oxide and alumina. | 2014-05-01 |
20140121315 | RESIN MOLDED BODY - Provided is a resin molded body which has excellent flame retardance, weather resistance, shock resistance and tracking resistance. The resin molded body is composed of a thermoplastic resin composition comprising a thermoplastic resin, a polycarbonate, an elastomer, and a flame retardant. By adopting this combination of components, a Charpy impact value at 23° C. measured in conformity with ISO 179/1eA is 15 kJ/m2 or more and flame retardance measured under a condition of thickness of 1.0 mm and in conformity with UL94 is V-0 or more, and a resin molded body which can be used favorably outdoors is produced. | 2014-05-01 |
20140121316 | SILANE FUNCTIONALIZED OLIGOMER AND RUBBER COMPOUND COMPRISING THE SAME - A rubber composition includes high molecular weight diene elastomer, 5 to 120 phr of silica, 0 to 100 phr of a carbon black, and a silane modified oligomer including diene monomers and optionally vinyl aromatic monomers in polymerized form, wherein the silane modified oligomer has a molecular weight of 1000 to 5000 g/mol. A method of making the rubber composition includes compound mixing the components of the rubber composition in situ. | 2014-05-01 |
20140121317 | COATING COMPOSITION FOR CHROMIUM THIN FILM - The object of the present invention is to provide a coating composition which can provide a coating film having excellent adhesion to a chromium thin film under various conditions, and sufficient scratch resistance, and the present invention provides a coating composition for a chromium thin film formed on a substrate, wherein the coating composition includes: an acrylic copolymer (A) having a phosphate group and a hydroxyl group other than a hydroxyl group in the phosphate group; isocyanate (B); and a metal chelate (C). | 2014-05-01 |
20140121318 | EMULSIFIED COMPOSITIONS COMPRISING CROSSLINKED POLYMERS CONTAINING BIOMASS DERIVED MATERIALS - Novel, crosslinked polymers using biomass derived materials, such as aldaric acids and derivatives, are provided. The polymers can be used as hydrogels and in antimicrobial compositions. | 2014-05-01 |
20140121319 | High Styrene High Vinyl Styrene-Butadiene Rubber With Narrow Molecular Weight Distribution And Methods For Preparation Thereof - A polymer having at least the following characteristics: (a) a block styrene content with more than 6 consecutive styrene units from about 15 to about 35 weight percent based on total styrene content in the polymer; (b) a vinyl content from about 25 to about 80 weight percent based on total amount of polymerized 1,3-diene; and (c) a styrene content from about 35 to about 75 weight percent based on total weight of polymer; and (d) a molecular weight distribution (Mw/Mn) of 1.5 or less. | 2014-05-01 |
20140121320 | IONOMERIC SILICONE THERMOPLASTIC ELASTOMERS - This invention relates to thermoplastic elastomers comprising at least one silicone ionomer. These thermoplastic elastomers may be reprocessed and/or recycled. | 2014-05-01 |
20140121321 | METHOD FOR POLYMERIZNG VINYLIDENE FLUORIDE - A process for manufacturing a dispersion of a vinylidene fluoride (VDF) thermoplastic polymer [polymer (F)], said process comprising polymerizing VDF in an aqueous phase comprising from 0.5 to 1.5 g/l of at least one surfactant of formula F—(CF | 2014-05-01 |
20140121322 | SUPERABSORBENT POLYMER PROCESS - The present invention relates to a continuous process for the production of a superabsorbent polymer comprising providing an acidic liquid aqueous monomer mixture containing dissolved oxygen; continuously feeding the aqueous monomer mixture to a reactor; introducing a source of carbonate or hydrogen carbonate into the aqueous monomer mixture prior to entry into the reactor thereby forming a gas phase comprising carbon dioxide and at least a part of the dissolved oxygen, the gas phase being dispersed in the liquid phase; subjecting the gas/liquid mixture to at least partial phase separation immediately prior to or after entry into the reactor and at least partially removing the separated gaseous phase; subjecting the liquid phase in the reactor to free-radical polymerization to obtain the superabsorbent polymer, and continuously removing the superabsorbent polymer from the reactor. | 2014-05-01 |
20140121323 | POLYMERS AND FLAME RETARDANT MATERIALS - Disclosed is a polymer including a polymer polymerized of a phosphorous-based monomer, a polymer polymerized of a nitrogen-based monomer, or a polymer polymerized of the phosphorous-based monomer and the nitrogen-based monomer. The phosphorous-based monomer has the formula as follows: | 2014-05-01 |
20140121324 | Mono- or Multi-Layer Film - A one- or multilayered film is presented, in which case the film comprises at least one layer that contains at least one thermoplastic olefin homo or copolymer, modified if need be. According to the invention, said layer contains additionally, at least, one polyester. In addition, the use of such film as sliding film or preliner in pipe renovation using the so-called tube lining technique is presented, in which case the film is used for laying it on the inner wall of a pipe laid underground that will be renovated, preferably a sewer pipe, so an insertion pipe with a curable carrier material can be pulled in sliding fashion over the sliding film laid on the pipe. The film according to the invention can also be used as packaging material for food or for the so-called non-food sector. | 2014-05-01 |
20140121325 | Propylene Copolymer Compositions and Processes to Produce Them - This invention relates to a process for producing propylene-based in-reactor compositions comprising: (a) contacting propylene and from about 0 wt % to 10 wt % C | 2014-05-01 |
20140121326 | METHOD FOR FORMING CONJUGATED HETEROAROMATIC HOMOPOLYMER AND COPOLYMER, AND PRODUCTS THEREOF - A method for forming a conjugated heteroaromatic polymer is described, wherein at least one compound of formula (1) is polymerized using an acid as a catalyst, | 2014-05-01 |
20140121327 | POLYMER POWDER FOR PRODUCING THREE-DIMENSIONAL OBJECTS - The invention relates to the use of a powder made of a polymer, which of two or more components with functionalities suitable for Diels-Alder reactions, or of a powder mixture (dry blend) made of powders respectively of at least one of the reactive components, where these together enter into the Diels-Alder reaction with one another and are capable of a retro-Diels-Alder reaction, in a rapid-prototyping process. | 2014-05-01 |
20140121328 | Polymer Scaffold Degradation Control Via Chemical Control - A variety of polymers and copolymers suitable for use as biologically compatible constructs and, as a non-limiting specific example, in the formation of degradable tissue scaffolds as well methods for synthesizing these polymers and copolymers are described. The polymers and copolymers have degradation rates that are substantially faster than those of previously described polymers suitable for the same uses. Copolymers having a synthesis route which enables one to fine tune the degradation rate by selecting the specific stoichiometry of the monomers in the resulting copolymer are also described. The disclosure also provides a novel synthesis route for maleoyl chloride which yields monomers suitable for use in the copolymer synthesis methods described herein. | 2014-05-01 |
20140121329 | Method for Producing Hydrogenated Conjugated Diene Copolymer - The present invention relates to a method for producing a hydrogenated conjugated diene copolymer including a polymerization step and a hydrogenation step, wherein in the polymerization step, a conjugated diene copolymer having a high vinyl bond amount of a conjugated diene block moiety and a narrow molecular weight distribution can be produced, and in the hydrogenation step, the rate of hydrogenation is high and productivity is excellent. | 2014-05-01 |
20140121330 | PROCESS FOR BROMINATING BUTADIENE POLYMERS USING ESTER SOLVENT MIXTURES - Butadiene copolymers are brominated using certain quaternary ammonium or phosphonium tribromides as the brominating agent. The bromination is performed in solution in a mixture of n-butyl acetate and ethyl acetate. The bromination process proceeds easily under mild conditions, and produces a brominated product that has excellent thermal stability. | 2014-05-01 |
20140121331 | TREATMENT METHOD FOR FLUORORESIN PELLETS - Provided is a treatment method for fluororesin pellets to remove hydrofluoric acid released from fluororesin pellets obtained by melt-molding a melt-moldable fluororesin. The treatment method comprises bringing a hydrofluoric acid-removing medium selected from warm water of from 30 to 200° C., steam of from 100 to 200° C. and warm wind of from 40 to 200° C. into contact with fluororesin pellets obtained by melt-molding a melt-moldable fluororesin, and thereby treating the fluororesin pellets so that the amount of hydrofluoric acid released per kg of the resulting fluororesin pellets would be at most 5 μg as determined after the storage of the resulting fluororesin pellets at 35° C. for 15 days. | 2014-05-01 |
20140121332 | PRODUCTION METHOD FOR BIODEGRADABLE POLYESTER COPOLYMER RESIN - There is provided a production method for a biodegradable resin using a relatively inexpensive compound as an aromatic dicarboxylic acid compound, wherein, during the process of producing a biodegradable resin in the form of an aliphatic-aromatic polyester copolymer, an aliphatic dihydroxyl compound used as a starting material is used in an amount of between 1 and 1.5 equivalent weight with respect to aliphatic and aromatic dicarboxylic acid compounds. The present invention includes the steps of: causing a hydroxyl group of the aliphatic dihydroxyl compound to undergo a first reaction with a carboxyl group of the aliphatic dicarboxylic acid compound; and causing the residual hydroxyl group of the aliphatic dihydroxyl compound to undergo a second reaction with a carboxyl group of the aromatic dicarboxylic acid compound. The present invention has the advantage that it is possible to produce the aliphatic-aromatic polyester copolymer biodegradable resin by means of an efficient method while not detracting from the mechanical properties of the biodegradable resin. | 2014-05-01 |
20140121333 | PERMANENT ATTACHMENT OF AGENTS TO SURFACES CONTAINING C-H FUNCTIONALITY - An embodiment of the present disclosure can include a compound, a structure bonded to the compound, and the like. In an embodiment, the compound can be a linker between an agent and a structure, where the agent can be a dye or a pigment and the structure can be a fiber, hair, or another structure. In an embodiment, the compound can be a linker between an agent and a structure, where the agent can be a fluorinated compound and the structure can be a counter top, metal, or the like. | 2014-05-01 |
20140121334 | Pressure Management for Slurry Polymerization - Processes and systems for the production for pressure management of a polymerization product flowing from a loop polymerization reactor to a separation vessel in a slurry polymerization system are disclosed herein. For example, a process comprises withdrawing the polymerization product from a loop polymerization reactor, and conveying the withdrawn polymerization product to a separation vessel via a first pressure differential and a second pressure differential. The withdrawn polymerization product may flow through the first pressure differential before flowing through the second pressure differential, and the first pressure differential may be less than the second pressure differential. | 2014-05-01 |
20140121335 | Pressure Management for Slurry Polymerization - Processes and systems for the production for pressure management of a polymerization product flowing from a loop polymerization reactor to a separation vessel in a slurry polymerization system are disclosed herein. For example, a process comprises withdrawing the polymerization product from a loop polymerization reactor, and conveying the withdrawn polymerization product to a separation vessel via a first pressure differential and a second pressure differential. The withdrawn polymerization product may flow through the first pressure differential before flowing through the second pressure differential, and the first pressure differential may be less than the second pressure differential. | 2014-05-01 |
20140121336 | METHOD FOR INCREASING PRODUCTION VOLUME OF FINE PARTICLES USING FORCED THIN FILM FLUID TREATMENT APPARATUS - The present invention addresses the problem of providing a new method for increasing the production of fine particles. Using at least two types of fluids to be processed, a raw material fluid containing at least one type of fine particle raw material and a fluid for treating the fine particle raw material, fine particles are obtained by mixing the fluids to be processed in a thin film fluid formed between at least two processing surfaces which are disposed to be faced with each other so as to be able to approach to and separate from each other, at least one of which rotates relative to the other. At this time, the production of the fine particles is increased by introducing the raw material fluid from the centers of the processing surfaces. | 2014-05-01 |
20140121337 | METHODS FOR PREPARATION OF PROPYLENE POLYMERS - Disclosed herein is a polymerization method of propylene, which can prepare a propylene homopolymer with both high fluidity and high rigidity as well as a propylene/α-define copolymer having both high fluidity and a good rigidity-toughness balance by, for example, control of polymerization steps and elevation of polymerization temperature, while the catalyst still maintains a relatively high polymerization activity. | 2014-05-01 |
20140121338 | PROCESS FOR THE PREPARATION OF THE MONOMER PENTABROMOBENZYL ACRYLATE AND POLYMERIZATION THEREOF - The invention relates to a process for preparing pentabromobenzyl acrylate through the reaction of pentahalobenzyl halide with a salt of acrylic acid in water-immiscible solvent, wherein said salt is in aqueous form and the reaction is carried out in the presence of a phase transfer catalyst. A process for polymerizing the pentabromobenzyl acrylate in halogenated aromatic solvent and the poly (pentabromobenzyl acrylate) obtained are also disclosed. | 2014-05-01 |
20140121339 | POLYPROPYLENE WITH NARROW MOLECULAR WEIGHT DISTRIBUTION RANGE AND PROCESSES FOR PREPARATION THEREOF - Disclosed herein are a polypropylene with narrow molecular weight distribution and a process for preparing the same in a reactor using a Ziegler-Natta catalyst. | 2014-05-01 |
20140121340 | POLYPROPYLENE FILMS AND SHEETS - Films or sheets of polypropylene, particularly biaxially oriented polypropylene (BOPP) films, exhibiting excellent physical and mechanical properties combined with good processing characteristics can be prepared from propylene polymers prepared in the presence of Ziegler-Natta catalysts comprising a succinate and a diether compound. | 2014-05-01 |
20140121341 | Supported Metallocene Catalyst Systems and Methods of Preparation Thereof - This invention relates to a process to produce a supported metallocene catalyst system, the process comprising: (i) contacting a support material with an alkyl aluminum compound to provide an alkyl aluminum treated support material; wherein the alkyl aluminum compound is represented by the formula: R | 2014-05-01 |
20140121342 | METHOD FOR PRODUCING VERY-HIGH OR ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE - The field of the invention relates generally to a method for preparing very-high or ultra-high molecular weight polyethylene. More particularly, the present invention related to a method of preparing very-high or ultra-high molecular weight polyethylene using a supported catalyst comprising a support, an activator and a metal-ligand complex, as well as the catalyst itself. The present invention additionally relates to a method of using a supported catalyst comprising a support, an activator and co-supported metal-ligand complexes to obtain a bi-modal molecular weight distribution of polyethylene. | 2014-05-01 |
20140121343 | Novel Catalyst Compositions and Methods of Making and Using Same - An imine phenol compound having Structure I: | 2014-05-01 |
20140121344 | Novel Catalyst Compositions and Methods of Making and Using Same - An ethylene polymer having (i) a density defined by equation (1) | 2014-05-01 |
20140121345 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED PRODUCT THEREOF - Provided is a liquid crystal alignment layer of which a constituent member is a compound represented by the general formula (I). | 2014-05-01 |
20140121346 | PROCESS AND APPARATUS FOR SUPERSONIC COLLISION SHOCKWAVE REACTION MECHANISM FOR MAKING CHEMICAL COMPOUNDS - A novel process and apparatus is disclosed for performing chemical reactions. Highly compressed gaseous streams such as H | 2014-05-01 |
20140121347 | HIGH MOLECULAR WEIGHT POLYLACTIC ACID SYNTHESIZED VIA POLYCONDENSATION CATALYZED BY BIONIC CREATININE GUANIDININIUM CHLORIDE - Disclosed is a high molecular weight polylactic acid synthesized by using a method for synthesizing and catalytically-polycondensing bionic creatinine-guanidinium chloride. Creatinine is used as the material in a reaction with aqueous hydrochloric acid to synthesize a bionic creatinine-guanidinium salt catalyst, creatinine-guanidinium chloride (CR.Cl). The creatinine-guanidinium chloride synthesized is used as a catalyst, an industrial grade lactic acid (LA, 85% to 90%, aqueous solution) is used as a monomer, a solvent-free two-step polycondensation method is used to synthesize and afford metal-free and toxic residue-free polylactic acid featuring high biological safety and high molecular weight. | 2014-05-01 |
20140121348 | POLYCARBONATE RESINS AND PROCESSES FOR PRODUCING THE SAME - The invention is to provide polycarbonate resins having excellent light resistance, transparency, hue, heat resistance, thermal stability, and mechanical strength and to provide processes for efficiently and stably producing a polycarbonate resin which stably shows those performances. The invention includes: polycarbonate resins which at least contain structural units derived from a dihydroxy compound having the portion represented by formula (1) as part of the structure thereof and which have specific properties; and processes for producing the polycarbonate resins, | 2014-05-01 |
20140121349 | MONOMERS, OLIGOMERIC COMPLEXES, COORDINATION POLYMERS, AND METHODS FOR THEIR PREPARATION AND USE - A hydrogel composition is formed by conveying separate first and second liquid components subject to a selectively applied application pressure P(A) into an outlet path for mixing and discharge. A liquid flushing agent is automatically conveyed into the outlet path subject to a substantially constantly applied purge pressure P(P) when the application of P(A) is interrupted, to continuously flush residual hydrogel composition from the outlet path. | 2014-05-01 |
20140121350 | POLYIMIDE-GRAPHENE COMPOSITE MATERIAL AND METHOD FOR PREPARING SAME - The present disclosure relates to a polyimide-graphene composite material and a method for preparing same. More particularly, it relates to a polyimide-graphene composite material prepared by adding modified graphene and a basic catalyst during polymerization of a polyimide precursor so as to improve mechanical strength and electrical conductivity and enable imidization at low temperature and a method for preparing same. | 2014-05-01 |
20140121351 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE - The invention relates to materials and methods of conjugating a water soluble polymer to an oxidized carbohydrate moiety of a therapeutic protein comprising contacting the oxidized carbohydrate moiety with an activated water soluble polymer under conditions that allow conjugation. More specifically, the present invention relates to the aforementioned materials and methods wherein the water soluble polymer contains an active aminooxy group and wherein an oxime or hydrazone linkage is formed between the oxidized carbohydrate moiety and the active aminooxy group on the water soluble polymer, and wherein the conjugation is carried out in the presence of a nucleophilic catalyst. | 2014-05-01 |
20140121352 | REVERSIBLE PEGYLATED DRUGS - Reversible pegylated drugs are provided by derivatization of free functional groups of the drug selected from amino, hydroxyl, mercapto, phosphate and/or carboxyl with groups sensitive to mild basic conditions such as 9-fluorenylmethoxycarbonyl (Fmoc) or 2-sulfo-9-fluorenylmethoxycarbonyl (FMS), to which group a PEG moiety is attached. In these pegylated drugs, the PEG moiety and the drug residue are not linked directly to each other, but rather both residues are linked to different positions of the scaffold Fmoc or FMS structure that is highly sensitive to bases and is removable under physiological conditions. The drugs are preferably drugs containing an amino group, most preferably peptides and proteins of low or medium molecular weight. Similar molecules are provided wherein a protein carrier or another polymer carrier replaces the PEG moiety. | 2014-05-01 |
20140121353 | INSULIN ANALOGUES OF PROLONGED ACTIVITY - New biosynthetic analogues of recombined human insulin of prolonged therapeutical activity, which can find place in prophylactic and treatment of diabetes. | 2014-05-01 |
20140121354 | Somatostatin-Dopamine Chimeric Analogs - The present invention relates to novel somatostatin-dopamine chimeric analogs and their therapeutic uses for the inhibition, prevention, and/or treatment of neoplasia, neuroendocrine tumors, Cushing's disease/syndrome, and other conditions. | 2014-05-01 |